BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11070430)

  • 1. The delta valve: how does its clinical performance compare with two other pressure differential valves without antisiphon control?
    Davis SE; Levy ML; McComb JG; Sposto R
    Pediatr Neurosurg; 2000 Aug; 33(2):58-63. PubMed ID: 11070430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of infantile hydrocephalus: "differential-pressure" or "flow-control" valves. A pilot study.
    Jain H; Sgouros S; Walsh AR; Hockley AD
    Childs Nerv Syst; 2000 Apr; 16(4):242-6. PubMed ID: 10855523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustable antisiphon shunt.
    Sood S; Canady AI; Ham SD
    Childs Nerv Syst; 1999 May; 15(5):246-9. PubMed ID: 10392496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory testing of hydrocephalus shunts -- conclusion of the U.K. Shunt evaluation programme.
    Czosnyka Z; Czosnyka M; Richards HK; Pickard JD
    Acta Neurochir (Wien); 2002 Jun; 144(6):525-38; discussion 538. PubMed ID: 12111485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
    Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
    Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid hydrodynamics after placement of a shunt with an antisiphon device: a long-term study.
    Lundkvist B; Eklund A; Kristensen B; Fagerlund M; Koskinen LO; Malm J
    J Neurosurg; 2001 May; 94(5):750-6. PubMed ID: 11354406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of fixed-pressure valve with antisiphon device SPHERA(®) in hydrocephalus treatment and overdrainage prevention.
    Pinto FC; Pereira RM; Saad F; Teixeira MJ
    Arq Neuropsiquiatr; 2012 Sep; 70(9):704-9. PubMed ID: 22990728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival rates of gravity-assisted, adjustable differential pressure valves in infants with hydrocephalus.
    Gebert AF; Schulz M; Schwarz K; Thomale UW
    J Neurosurg Pediatr; 2016 May; 17(5):544-51. PubMed ID: 26799410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shunt Devices for the Treatment of Adult Hydrocephalus: Recent Progress and Characteristics.
    Miyake H
    Neurol Med Chir (Tokyo); 2016 May; 56(5):274-83. PubMed ID: 27041631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of structural degradation of cerebrospinal fluid shunt valves performed using scanning electron microscopy and energy-dispersive x-ray microanalysis.
    Sgouros S; Dipple SJ
    J Neurosurg; 2004 Mar; 100(3):534-40. PubMed ID: 15035291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus.
    McGirt MJ; Buck DW; Sciubba D; Woodworth GF; Carson B; Weingart J; Jallo G
    Childs Nerv Syst; 2007 Mar; 23(3):289-95. PubMed ID: 17106749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posture-related overdrainage: comparison of the performance of 10 hydrocephalus shunts in vitro.
    Czosnyka Z; Czosnyka M; Richards HK; Pickard JD
    Neurosurgery; 1998 Feb; 42(2):327-33; discussion 333-4. PubMed ID: 9482183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting.
    Kehler U; Kiefer M; Eymann R; Wagner W; Tschan CA; Langer N; Rohde V; Ludwig HC; Gliemroth J; Meier U; Lemcke J; Thomale UW; Fritsch M; Krauss JK; Mirzayan MJ; Schuhmann M; Huthmann A
    Clin Neurol Neurosurg; 2015 Oct; 137():132-6. PubMed ID: 26196478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shunt survival rates by using the adjustable differential pressure valve combined with a gravitational unit (proGAV) in pediatric neurosurgery.
    Thomale UW; Gebert AF; Haberl H; Schulz M
    Childs Nerv Syst; 2013 Mar; 29(3):425-31. PubMed ID: 23135777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of normal-pressure hydrocephalus: comparison of flow-regulated and differential-pressure shunt valves.
    Weiner HL; Constantini S; Cohen H; Wisoff JH
    Neurosurgery; 1995 Nov; 37(5):877-84. PubMed ID: 8559335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shunting with gravitational valves--can adjustments end the era of revisions for overdrainage-related events?: clinical article.
    Freimann FB; Sprung C
    J Neurosurg; 2012 Dec; 117(6):1197-204. PubMed ID: 22998061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
    Pollack IF; Albright AL; Adelson PD
    Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
    Meling TR; Egge A; Due-Tønnessen B
    Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the Strata valve in the management of shunt overdrainage.
    Kondageski C; Thompson D; Reynolds M; Hayward RD
    J Neurosurg; 2007 Feb; 106(2 Suppl):95-102. PubMed ID: 17330533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.